News | July 23, 2010

Point-of-Care Analyzer May Speed ER Cardiac Evaluations

July 23, 2010 – For patients suffering from a heart attack, every minute counts, yet the average time from start of chest pain to receiving emergency room (ER) medical attention is 3.2 hours. The average turn-around time of lab-based test results is 2.8 hours, with the minimum time to detect a heart attack using today’s lab-based immunodiagnostics is 4.5 hours from symptom outset.

When it comes to cardiac events and survival, the key factors for a successful recovery are time to diagnosis, accuracy of diagnosis, and appropriate clinical management. For these reasons point-of-care (POC) testing for chest pain patients may help improve patient survival.

Ontario-based CardioGenics has created improved cardiac diagnostic testing that boasts faster results, better accuracy, at reduced cost to the patient and caregiver. The analyzer offers advantages over existing POC immunoassay technology, which the company compares to the shift from portable CD players to iPods. In six steps, the QL Care Analyzer provides printed medical lab quality results in less than 15 minutes. Capable of delivering test results in the ER, doctor’s office, or EMS vehicle, the single-use cartridge QL Care Analyzer is the size of a portable CD player, features an intuitive user interface touch screen, and is capable of storing patient data for up to 5,000 individuals.

The QL Care Analyzer is being submitted to the U.S. Food and Drug Administration (FDA) this summer for testing of troponin I, a protein that is integral to cardiac muscle and its blood level measures the presence and severity of a heart attack.

CardioGenics believes that the device cartridge can ultimately be adapted to run any number of immunoassay tests. (There are approximately 200 different immunoassays for HIV, cancer, thyroid conditions, etc., that are currently performed by lab-based analyzers).

For more information: www.cardiogenics.com

Related Content

FDA Clears Abbott's High Sensitivity Troponin-I Blood Test
Technology | Blood Testing | October 09, 2019
Abbott recently announced that its Architect Stat High Sensitivity Troponin-I blood test has received clearance from...
Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes
News | Blood Testing | September 18, 2019
Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high-sensitivity cardiac troponin T...
Validation Studies Confirm High Accuracy of Novel HART AI-Driven Blood Tests
News | Blood Testing | March 19, 2019
Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven, multiple-protein...
CoaguChek XS PT Test Strips Recalled for Inaccurately Reporting High INR
News | Blood Testing | December 28, 2018
Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche CoaguChek test strips, as...
Abbott Point-of-Care Blood Test Speeds Heart Attack Diagnosis
News | Blood Testing | October 26, 2018
For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether...
New Noninvasive Blood Glucose Test as Effective as Finger Prick

Image courtesy of University of Missouri School of Medicine

News | Blood Testing | October 24, 2018
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related...
Abbott Receives CE Mark for High Sensitive Troponin-I Test
News | Blood Testing | October 16, 2018
October 16, 2018 — Abbott announced that its High Sensitive Troponin-I...
AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018
Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD)...
More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018
August 6, 2018 — A new test to assess a whether or not someone is having a...
Singulex cTnl Assay Can Identify Presence, Severity of CAD in Stable, Symptomatic Outpatients
News | Blood Testing | March 26, 2018
March 26, 2018 — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singule